webinar register page

Webinar banner
Pharmaceutical Industry post COVID 19: Ensuring patients safety by curbing substandard and falsified
The demand for medical supplies soars worldwide in the fight against COVID-19, there is a parallel risk of substandard and counterfeit medicines in the global market.
Topics of Discussion:
• Safeguard the quality of biopharma & global initiatives in curbing falsified.
• The current state of science of immunology & clinical research of COVID 19
• The pharma supply chain after COVID -19
• Evaluating Pharma Amid COVID-19
• Regulatory framework amendments required to curb the substandard and falsified.

Aug 8, 2020 02:00 PM in India

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Messe Frankfurt India.